Projected Burden of Bloodstream Infections and the Impact of Molecular Rapid Diagnostic Testing in England and the United States (2025–2029)

Karichu JK, Pennington M, Lander K, Smith TT, Thornberg A.

Open source

DOI
10.64898/2026.03.18.26348587
Published
2026-03-20
Container
Not recorded
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.64898/2026.03.18.26348587,
  title = {Projected Burden of Bloodstream Infections and the Impact of Molecular Rapid Diagnostic Testing in England and the United States (2025–2029)},
  author = {Karichu JK and  Pennington M and  Lander K and  Smith TT and  Thornberg A.},
  year = {2026},
  doi = {10.64898/2026.03.18.26348587},
  url = {https://doi.org/10.64898/2026.03.18.26348587}
}

RIS

TY  - JOUR
TI  - Projected Burden of Bloodstream Infections and the Impact of Molecular Rapid Diagnostic Testing in England and the United States (2025–2029)
AU  - Karichu JK
AU  -  Pennington M
AU  -  Lander K
AU  -  Smith TT
AU  -  Thornberg A.
PY  - 2026
DO  - 10.64898/2026.03.18.26348587
UR  - https://doi.org/10.64898/2026.03.18.26348587
ER  - 

APA

JK, K., M, P., K, L., TT, S., & A., T. (2026). Projected Burden of Bloodstream Infections and the Impact of Molecular Rapid Diagnostic Testing in England and the United States (2025–2029). https://doi.org/10.64898/2026.03.18.26348587

Source records